About This Webinar
Martin Warman and Paul Gillham address the need for and processes involved in improving in-line monitoring software for pharmaceutical manufacturing.
***This presentation premiered during the 2022
Photonics Spectra Spectroscopy Conference. For more information on Photonics Media conferences, visit
events.photonics.com.
About the presenters:
Martin Warman is director of Martin Warman Consultancy Ltd. He has recently stepped down as a professor of practice at the University of Strathclyde, and from being the research director for the Medicine Manufacturing Innovation Centre (MMIC) but continues to work with the MMIC in a consultancy role. He worked previously for seven years at Vertex Pharmaceuticals, developing the Vertex continuous manufacturing (CM) platform, on which the first approved CM products are manufactured. He has over 25 years of experience in the field of process development, having previously led the Global Process Analytical Technology (PAT) Development Team at Pfizer Global Manufacturing. He plays an active role in ASTM E55 as the technical lead on standards for PAT sampling, PAT-enabled control systems, and CM. Warman is also an associate member of Centre for Process Analytics and Control Technology (CPACT).
Paul Gillham is director of innovation at Optimal Industrial Technologies Ltd. in the UK. He has more than a decade of experience in PAT, software, and compliance—especially for quality-by-design (QbD) innovation in pharmaceutical manufacturing.